Applications of Pharmacokinetics

Slides:



Advertisements
Similar presentations
PHARMACOKINETIC MODELS
Advertisements

First, zero, pseudo-zero order elimination Clearance
PHARMACOKINETIC.
Mathematic descript. of A) Biolog. processes affecting drugs B) Biolog. processes affected by drugs drugs Pharmacokinetics Mathematical expressions to.
Evaluation of quality and interchangeability of medicinal products - EAC/EC/WHO Training workshop / September |1 | Prequalification programme:
Selected bioavailability and pharmacokinetic calculations Dr. Osama A. A. Ahmed.
Pharmacokinetics of Drug Absorption
Nonlinear pharmacokinetics
One-compartment open model: Intravenous bolus administration
Laplace transformation
Practical Pharmacokinetics
Practical Pharmacokinetics September 11, 2007 Frank F. Vincenzi.
Modeling Systems and Processes Anthony McGoron, PhD Associate Professor Department of Biomedical Engineering Florida International University.
Gokaraju Rangaraju College of Pharmacy
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
Week 6- Bioavailability and Bioequivalence
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
Pharmacokinetics Introduction
Fundamentals of Drug Action
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
FARMAKOKINETIKA. INTRODUCTION Historically, pharmaceutical scientists have evaluated the relative drug availability to the body in vivo after giving a.
BASIC PHARMACOKINETIC PARAMETERS. PHARMACOKINETICS Pharmacokinetics is the study of the time course of a drug within the body and incorporates the processes.
PHARMACOKINETIC MODELS
Touqeer Ahmed Ph.D. Atta-ur-Rahman School of Applied Bioscience, National University of Sciences and Technology 21 st October, 2013.
Pharmacokinetics of Drug Absorption Prepared by: KAZI RASHIDUL AZAM.
Area under the plasma concentration time curve. IMPORTANCE OF AUC Pharmacokinetics - measurement of bioavaibility absolute, relative Biopharmaceutics.
Biopharmaceutics refers to the relationship of the:
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
The General Concepts of Pharmacokinetics and Pharmacodynamics
Multiple dosing: intravenous bolus administration
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
Bioavailability Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University Tobruk, Libya.
Clinical Pharmacokinetics Fundamental hypothesis: a relationship exists between the pharmacological or toxic response to a drug and the accessible concentration.
Continuous intravenous infusion (one-compartment model)
INTRODUCTION CLINICAL PHARMACOKINETICS
BIOPHARMACEUTICS.
1 Pharmacokinetics: Introduction Dr Mohammad Issa.
Pharmacokinetic Models
Study Aids Anki Flash cards – Content that you need to know for the tests. MS Excel sheet with Calculations.
DEFINITIONS T1/2 & Tmax Cmax AUC 1st order kinetics
PHT 415 BASIC PHARMACOKINETICS
The General Concepts of Pharmacokinetics and Pharmacodynamics
415 PHT Plasma Level – Time Curve
Learning objectives To know what data is available from pharmacokinetic studies in man and how to handle it To know how to calculate the basic pharmacokinetic.
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
MULTIPLE DOSAGE REGIMEN
Drug Response Relationships
Compartmental Models and Volume of Distribution
Physiology for Engineers
Chapter 8 BIOAVAILABILITY & BIOEQUIVALENCE
Introduction of Biopharmaceutics & Pharmacokinetics
Chapter 7 COMPARTMENT MODELS
CONCEPT OF PHARMACOKINETICS- ONE COMPARTMENT MODEL
Absorbtion of Bioactive Compounds
Dissolution testing and in vitro in vivo correlation of conventional and SR preparations Formulation development and optimization is an ongoing process.
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Controlled drug release
Biopharmaceutics Ali K. Alobaidy.
Lab-3 practical pharmacology
Quantitative Pharmacokinetics
Selected Bioavailability and Pharmacokinetic Calculations
1 Concentration-time curve
Therapeutic Drug Monitoring chapter 1 part 1
Plasma concentration–time profile, relative bioavailability and pharmacokinetic (PK) parameters of 4 mg TAK-228 in the single-agent QD PK run-in period,
Project #1: Drug Kinetics in Genetically Modified Mice
Drug levels during the course of a dosing interval.
Plasma concentration-time profile after oral administration of a single dose. Plasma concentration-time profile after oral administration of a single dose.
Presentation transcript:

Applications of Pharmacokinetics

Rational & Optimal therapy Right Balance between Therapeutic & Tox Applications of Pharmacokinetics Right DRUG Rational & Optimal therapy Right Balance between Therapeutic & Tox

Applications of Pharmacokinetics Ratio Right Balance between Therapeutic & Tox effects Drug Concentration at Site Drug Concentration in Plasma

Applications of Pharmacokinetics Ratio Applications of Pharmacokinetics Max effective conc This is where we want to maintain drug concentration for optimal benefit Therapeutic Window Drug Conc Minimum effective conc Time

Applications of Pharmacokinetics Ratio So for optimal dosing, we need to know mechanism of ADME as well as “KINETICS” of ADME Max effective conc This is where we want to maintain drug concentration for optimal benefit Therapeutic Window Drug Conc Minimum effective conc Time

Key Pharmacokinetic Parameters Ratio Cmax Maximum drug conc, peak plasma conc Cmax depends on Dose Rate of absorption Rate of elimination At Cmax; Rate of absorption = Rate of elimination Ideally, Min effect conc < Cmax < Max effective conc Drug Conc Time

Key Pharmacokinetic Parameters Ratio Tmax Time to reach peak plasma conc Reflects rate of absorption Onset time, Onset of action depends on Tmax Drug Conc Tmax Time

Key Pharmacokinetic Parameters Ratio AUC Area Under the curve Represents amount of drug that enters systemic circulation after administration Represents extent of absorption Important parameter to estimate bioavailability Drug Conc Time

Pharmacokinetic Analysis Ratio Pharmacokinetic Analysis Drug absorption, distribution, elimination is complex process We need simple approach to DESCRIBE, ANALYSE & INTERPRET PK data Drug Conc Time

Pharmacokinetic Analysis Ratio Pharmacokinetic Analysis Two major approaches to quantitative study of PK data Model Based approach Model-Independent approach Drug Conc Time

That uses mathematical terms Ratio Model- Based approach What's a PK MODEL ?? It’s a HYPOTHESIS Drug Conc That uses mathematical terms To describe PK data Time Hypothesis is a proposed explanation, in this case of drug ADME process

Ratio Types of PK Models Compartment Model Physiological Model

What are Compartment Model ? Ratio What are Compartment Model ? As the name suggest, body is assumed to be made up of “Compartments” These compartment are connected to each other Within each compartment, the drug get’s rapidly distributed & uniformly distributed (Well stirred model)

THANK YOU -PHARMA STREET